OXCT1
Basic information
Region (hg38): 5:41730065-41870425
Previous symbols: [ "OXCT" ]
Links
Phenotypes
GenCC
Source:
- succinyl-CoA:3-ketoacid CoA transferase deficiency (Definitive), mode of inheritance: AR
- succinyl-CoA:3-ketoacid CoA transferase deficiency (Strong), mode of inheritance: AR
- succinyl-CoA:3-ketoacid CoA transferase deficiency (Strong), mode of inheritance: AR
- succinyl-CoA:3-ketoacid CoA transferase deficiency (Strong), mode of inheritance: AR
- succinyl-CoA:3-ketoacid CoA transferase deficiency (Definitive), mode of inheritance: AR
- succinyl-CoA:3-ketoacid CoA transferase deficiency (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Succinyl CoA:3-oxoacid CoA transferase deficiency | AR | Biochemical | Diagnosis may allow prompt recognition and treatment of ketoacidotic episodes (eg, with IV glucose and sodium bicarbonate), which may be beneficial to reduce morbidity and mortality | Biochemical | 4258782; 1405472; 8751852; 9521962; 10964512; 11286388; 11757586; 20652411 |
ClinVar
This is a list of variants' phenotypes submitted to
- Succinyl-CoA_acetoacetate_transferase_deficiency (154 variants)
- Inborn_genetic_diseases (34 variants)
- not_provided (23 variants)
- OXCT1-related_disorder (15 variants)
- not_specified (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OXCT1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000436.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 41 | 44 | ||||
missense | 76 | 89 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 9 | 12 | 78 | 45 | 3 |
Highest pathogenic variant AF is 0.000042202
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OXCT1 | protein_coding | protein_coding | ENST00000196371 | 17 | 140455 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00473 | 0.995 | 125723 | 0 | 25 | 125748 | 0.0000994 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.57 | 169 | 293 | 0.578 | 0.0000153 | 3390 |
Missense in Polyphen | 24 | 94.938 | 0.2528 | 1158 | ||
Synonymous | -0.841 | 111 | 100 | 1.11 | 0.00000546 | 1004 |
Loss of Function | 3.53 | 10 | 31.3 | 0.319 | 0.00000172 | 372 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000174 | 0.000174 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000132 | 0.000132 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Key enzyme for ketone body catabolism. Transfers the CoA moiety from succinate to acetoacetate. Formation of the enzyme-CoA intermediate proceeds via an unstable anhydride species formed between the carboxylate groups of the enzyme and substrate.;
- Pathway
- Butanoate metabolism - Homo sapiens (human);Synthesis and degradation of ketone bodies - Homo sapiens (human);Valine, leucine and isoleucine degradation - Homo sapiens (human);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Maple Syrup Urine Disease;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Succinyl CoA: 3-ketoacid CoA transferase deficiency;Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Ketone Body Metabolism;Butyrate Metabolism;Beta-Ketothiolase Deficiency;Synthesis and Degradation of Ketone Bodies;ketolysis;Butanoate metabolism;Metabolism of lipids;Metabolism;Utilization of Ketone Bodies;Ketone body metabolism;Butanoate metabolism;Valine Leucine Isoleucine degradation
(Consensus)
Intolerance Scores
- loftool
- 0.212
- rvis_EVS
- -0.2
- rvis_percentile_EVS
- 38.82
Haploinsufficiency Scores
- pHI
- 0.100
- hipred
- N
- hipred_score
- 0.471
- ghis
- 0.492
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.375
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Oxct1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- brain development;heart development;response to nutrient;response to hormone;response to activity;positive regulation of insulin secretion involved in cellular response to glucose stimulus;ketone catabolic process;response to starvation;response to ethanol;cellular ketone body metabolic process;ketone body catabolic process;adipose tissue development
- Cellular component
- nucleoplasm;mitochondrion;mitochondrial matrix
- Molecular function
- 3-oxoacid CoA-transferase activity;protein homodimerization activity